scispace - formally typeset
C

Cees G. M. Kallenberg

Researcher at University Medical Center Groningen

Publications -  234
Citations -  10639

Cees G. M. Kallenberg is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Vasculitis & Autoantibody. The author has an hindex of 56, co-authored 234 publications receiving 9786 citations.

Papers
More filters
Journal ArticleDOI

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

TL;DR: Recommendations for the management of lupus nephritis were developed using an evidence-based approach followed by expert consensus and there is no evidence to suggest that management of LN should differ in children versus adults.
Journal ArticleDOI

The complement system in systemic autoimmune disease

TL;DR: Insight into the role of the various pathways of complement in the systemic autoimmune diseases including the vasculitides opens up new ways of treatment by blocking effector pathway of complement.
Journal ArticleDOI

Transancestral mapping and genetic load in systemic lupus erythematosus

Carl D. Langefeld, +116 more
TL;DR: A large transancestral association study of SLE using Immunochip genotype data from 27,574 individuals of European, African and Hispanic Amerindian ancestry identifies both ancestry-dependent and ancestry-independent contributions to SLE risk.
Journal ArticleDOI

Health-related quality of life, employment and disability in patients with Sjögren's syndrome

TL;DR: SS has a large impact on HR-QOL, employment and disability, and employment was lower and DC rates were higher in SS patients compared with the Dutch population.
Journal ArticleDOI

Differential B- and T-cell activation in Wegener's granulomatosis.

TL;DR: In this article, the relation between lymphocyte activation and disease activity in patients with Wegener's granulomatosis was investigated by cytometric assessment of the expression of the activation markers CD38 on B cells and CD25 and HLA-DR on CD4 + and CD8 + T-cell subsets, respectively.